Pneumolysin: a double-edged sword during the host-pathogen interaction.
about
The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytesFighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsInteractions between blood-borne Streptococcus pneumoniae and the blood-brain barrier preceding meningitisThe host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentPneumococcal hydrogen peroxide-induced stress signaling regulates inflammatory genesThe human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agentsOverview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseRandomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsType I interferon signaling regulates activation of the absent in melanoma 2 inflammasome during Streptococcus pneumoniae infection.Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemIncreased Zinc Availability Enhances Initial Aggregation and Biofilm Formation of Streptococcus pneumoniaeImpaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adultsLevofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challengeInspecting the potential physiological and biomedical value of 44 conserved uncharacterised proteins of Streptococcus pneumoniaeMouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced diseaseThe proteasome-ubiquitin system is required for efficient killing of intracellular Streptococcus pneumoniae by brain endothelial cellsStreptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infectionActivation and proteolytic activity of the Treponema pallidum metalloprotease, pallilysin.Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins.Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain.Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity.Deletion of a cation transporter promotes lysis in Streptococcus pneumoniae.Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection.Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone childrenSynchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injuryPacking a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsMultivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.Insights into the Evolutionary Relationships of LytA Autolysin and Ply Pneumolysin-Like Genes in Streptococcus pneumoniae and Related Streptococci.Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin releaseStatin-conferred enhanced cellular resistance against bacterial pore-forming toxins in airway epithelial cellsAntibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children.Next generation protein based Streptococcus pneumoniae vaccines
P2860
Q21089605-DAD0BA08-EC38-4313-BAC7-4A33DDE5638DQ26774211-E5D3D74D-9D43-4D4C-AD7C-3252199AACDEQ27311470-79BDED53-8E8A-4D16-8507-75E9FB072DC9Q28084920-E61BA395-DFED-4519-92D9-57A87D476AD2Q28388186-E5072CC3-56A4-411E-B27D-56AC076CE382Q28482276-4B925160-9D5E-474B-8F5D-80D0F38BE88BQ30358199-0B559053-4CFD-44D7-80AF-D80956A46920Q30492867-4F09994C-0A2B-4E27-945B-1711F485636DQ33601853-8B3F3030-5A10-48FB-81C5-25701658AAB4Q33602937-0DB141E0-6111-4FBE-839A-B907D857157CQ33664362-CE91336D-3ADC-4977-8044-B7841467299EQ33770464-5CCB59DD-F08F-427A-9972-3EAEDDEEDD20Q34043394-F3512412-C723-4754-8518-85DF7E0FE4A5Q34057612-2B7C218C-7AA0-46B3-9268-A4B8D1E0B4F9Q34057765-C1D488DE-A33A-4056-A9C0-70821C469A54Q34085006-C14036BD-7546-459D-BA46-54DF60A8F385Q34134769-603B4157-8EF2-4251-96BB-9E2FCF594CFFQ34149169-1CDD43BB-B069-4422-BE27-199EB163F981Q34165387-2F51A3F4-81B9-4A97-A119-552D25B5E6B4Q34229862-0F2D095E-79E7-4218-97C7-D6C6E2C67BEEQ34350904-BD032092-6AD2-4C08-8D0F-4FB944BA76C5Q34387058-0123A26D-E9C1-4907-A4C6-21543235D105Q34595710-2460A76F-B7BA-46F0-A70E-6D738B14C505Q34637890-5195DDF6-BAA2-4017-ACD1-12243D9DBC72Q34727874-EA2CB865-DC2B-44EF-84AA-315F3F4F0069Q34955732-C2076B7C-687A-433B-9F70-3103A3382866Q35032403-D4C793D3-0538-4FBB-8E12-4A4F001F2510Q35075803-C937368C-7035-416B-845B-3DDB691E1C99Q35403384-CCFC40E1-B3C6-4104-8CB6-09A46A3F4445Q35811715-5B36C4C9-1C95-4B91-988C-49C38AEE94E8Q35887453-DCBED825-7C74-41C1-A2BB-0FAD8F435C36Q36018158-8884029F-D369-4093-8BA9-FBF17246B0CAQ36059050-59AAA8F9-C6AE-4785-BA96-72165DD97FFEQ36072425-15275C7A-EF2E-4C9A-834E-46E6C7E26E28Q36087567-FB899EEE-D622-49B6-8393-F0D1CD25BE60Q36166712-CE43424D-CD00-409B-B49F-E2B6C8339A50Q36187763-47DB52E8-3A01-4EF5-A073-27342354BF41Q36549172-D1AA18CB-9D7D-4FF3-A40B-71B2C9509A25Q36920037-885C02CC-D336-4098-B592-62B1C6B4D848Q37130191-4E0D2ACC-37AE-41C1-97D1-AFCE778FCF0C
P2860
Pneumolysin: a double-edged sword during the host-pathogen interaction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@ast
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@en
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@nl
type
label
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@ast
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@en
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@nl
prefLabel
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@ast
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@en
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@nl
P2093
P1476
Pneumolysin: a double-edged sword during the host-pathogen interaction.
@en
P2093
David H Dockrell
Helen M Marriott
Timothy J Mitchell
P304
P356
10.2174/156652408785747924
P577
2008-09-01T00:00:00Z